Edison Bellarmin

Edison Bellarmin is a seasoned professional with over a decade of experience in the medical technology industry, currently serving as the CEO at Beta MedTech Pte Ltd.

He is highly focused on improving the quality of life, enhancing clinical outcomes, and reducing healthcare costs by leveraging proprietary sensors and special algorithms to predict and prevent pressure injuries.

Before his role at Beta MedTech, Edison held key positions in renowned organizations such as Becton Dickinson Medical, Novartis Group, and Mundipharma, where he excelled in developing and commercializing new innovative medical products.

His expertise spans from concept ideation to commercialization, with a specific emphasis on product development in wound care, oral health, pain management, skincare, respiratory health, feminine care, and infection control products.

Edison's skill set includes strategic planning, project management, financial management, bio-compatibility assessments for medical devices, and the development of cosmetic products.

He has a strong academic background with a Ph.D. in Chemistry, an MSc in Chemistry, a BSc in Chemistry, an Executive Certificate in Engineering Leadership, an Advanced Certificate in Technopreneurship, and an MBA in Business Administration and Management.

Specializing in new product development, technology knowledge, cross-functional team management, and strategic innovation, Edison Bellarmin is a trusted leader in the medical technology sector.